Multi Immunotherapy to Test Tolerance and Xolair

NCT02626611 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Food Allergy

Interventions

DRUG: Omalizumab
DRUG: Food Flour Buildup

Sponsor

Kari Christine Nadeau

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]